Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06881017What this trial is testingEstablishment of Precision Targeted Therapy Strategies for Advanced Gastric Cancer Based on Novel Molecular SubtypingWho this might be right forGastric CancerHER2 + Gastric CancerCLDN18.2-positive Adenocarcinoma of the Gastroesophageal Junction+1 more China Medical University, China 140
Large-scale testing (Phase 3)Study completedNCT02578368What this trial is testingChemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionWho this might be right forGastric Cancer Krankenhaus Nordwest 183
Testing effectiveness (Phase 2)Looking for participantsNCT07000253What this trial is testingTiming of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaWho this might be right forEsophageal CancerGastric (Stomach) CancerGastric Adenocarcinoma+3 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 290
Testing effectiveness (Phase 2)Study completedNCT01983878What this trial is testingRamucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction CancerWho this might be right forGastric Cancer Eli Lilly and Company 36
Testing effectiveness (Phase 2)Study completedNCT00077545What this trial is testing3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusRecurrent Esophageal CancerStage IV Esophageal Cancer National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 680
Large-scale testing (Phase 3)Study completedNCT03615326What this trial is testingPembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)Who this might be right forGastric NeoplasmsGastroesophageal Junction Adenocarcinoma Merck Sharp & Dohme LLC 738
Not applicableStudy completedNCT02130011What this trial is testingDose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real DoseWho this might be right forAdenocarcinoma Maastricht Radiation Oncology 20
Testing effectiveness (Phase 2)Study completedNCT06238752What this trial is testingFirst-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GCWho this might be right forAdvanced Gastric Adenocarcinoma Renmin Hospital of Wuhan University 33
Testing effectiveness (Phase 2)Study completedNCT00045526What this trial is testingErlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT06445972What this trial is testingSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Who this might be right forGastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more Merck Sharp & Dohme LLC 210
Testing effectiveness (Phase 2)WithdrawnNCT06967987What this trial is testingStudy Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2bWho this might be right forGastric and Gastro-oesophageal Junction (GEJ) AdenocarcinomasOverexpression FGFR2b Institut Cancerologie de l'Ouest
Testing effectiveness (Phase 2)Looking for participantsNCT06750185What this trial is testingSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor BioNTech SE 248
Large-scale testing (Phase 3)Study completedNCT01170663What this trial is testingPaclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric AdenocarcinomaWho this might be right forGastric Cancer Eli Lilly and Company 665
Testing effectiveness (Phase 2)UnknownNCT03588533What this trial is testingHerzuma-capecitabine/Cisplatin for Gastric CancerWho this might be right forHER-2 Positive Gastric CancerMetastatic Cancer Sung Yong Oh 50
Testing effectiveness (Phase 2)WithdrawnNCT05245760What this trial is testingChemoRadiation And Tislelizumab for Esophageal/EGJ CancerWho this might be right forEsophageal CancerEsophagogastric Junction Cancer Zhonglin Hao
Post-approval studies (Phase 4)Not Yet RecruitingNCT06499610What this trial is testingClinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric CancerWho this might be right forGastric Cancer First Affiliated Hospital Xi'an Jiaotong University 44
Testing effectiveness (Phase 2)Study completedNCT03083613What this trial is testingRaltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Chinese Academy of Medical Sciences 41
Large-scale testing (Phase 3)Looking for participantsNCT04342910What this trial is testingStudy to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCWho this might be right forGastric Cancer Jiangsu HengRui Medicine Co., Ltd. 550